anti-VEGF (Bevacizumab)
- Catalog Number : A510013
- Number : A510013-1mg
-
Size:
Qty : - Price : Request Inquiry
-
Introduction
Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa.
General Information
| Reactivity | Human |
|---|---|
| Application | Functional Assay |
| Host | CHO cells |
| Clonality | Monoclonal |
| Conjugate | Non-conjugated |
| Isotype | Human IgG1 |
| Cas No. | 216974-75-3 |
| Purity | >95%; < 0.75 EU/mg as determined by the LAL method |
| Molecular Weight | 149 kDa |
| Storage buffer | 0.01 M phosphate buffered saline (PBS) pH 7.2 |
| Storage instruction | This solution is stable for at least 4 weeks when stored at 2-8°C. For long term storage aseptically aliquot and store at –80°C.Avoid repeated freeze/thaw cycles. |
| Alias | rhuMab VEGF, Avastin |
.png)